Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

1.

3,4-methylenedioxymethamphetamine (MDMA): current perspectives.

Meyer JS.

Subst Abuse Rehabil. 2013 Nov 21;4:83-99. doi: 10.2147/SAR.S37258. eCollection 2013. Review.

PMID:
24648791
[PubMed]
Free PMC Article
2.

Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.

Watkins TJ, Raj V, Lee J, Dietrich MS, Cao A, Blackford JU, Salomon RM, Park S, Benningfield MM, Di Iorio CR, Cowan RL.

Psychopharmacology (Berl). 2013 May;227(1):41-54. doi: 10.1007/s00213-012-2936-1. Epub 2012 Dec 16.

PMID:
23241648
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase.

Anneken JH, Cunningham JI, Collins SA, Yamamoto BK, Gudelsky GA.

J Neuroimmune Pharmacol. 2013 Mar;8(1):58-65. doi: 10.1007/s11481-012-9420-x. Epub 2012 Nov 18.

PMID:
23179355
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.

Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B, Michel Y, Brewerton TD, Doblin R.

J Psychopharmacol. 2013 Jan;27(1):28-39. doi: 10.1177/0269881112456611. Epub 2012 Nov 20.

PMID:
23172889
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): the influence of gender and genetics (CYP2D6, COMT, 5-HTT).

Pardo-Lozano R, Farré M, Yubero-Lahoz S, O'Mathúna B, Torrens M, Mustata C, Pérez-Mañá C, Langohr K, Cuyàs E, Carbó Ml, de la Torre R.

PLoS One. 2012;7(10):e47599. doi: 10.1371/journal.pone.0047599. Epub 2012 Oct 24.

PMID:
23112822
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The influence of genetic and environmental factors among MDMA users in cognitive performance.

Cuyàs E, Verdejo-García A, Fagundo AB, Khymenets O, Rodríguez J, Cuenca A, de Sola Llopis S, Langohr K, Peña-Casanova J, Torrens M, Martín-Santos R, Farré M, de la Torre R.

PLoS One. 2011;6(11):e27206. doi: 10.1371/journal.pone.0027206. Epub 2011 Nov 16.

PMID:
22110616
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Procedural and declarative memory task performance, and the memory consolidation function of sleep, in recent and abstinent ecstasy/MDMA users.

Blagrove M, Seddon J, George S, Parrott AC, Stickgold R, Walker MP, Jones KA, Morgan MJ.

J Psychopharmacol. 2011 Apr;25(4):465-77. doi: 10.1177/0269881110372545. Epub 2010 Jul 8.

PMID:
20615932
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.

Kish SJ, Lerch J, Furukawa Y, Tong J, McCluskey T, Wilkins D, Houle S, Meyer J, Mundo E, Wilson AA, Rusjan PM, Saint-Cyr JA, Guttman M, Collins DL, Shapiro C, Warsh JJ, Boileau I.

Brain. 2010 Jun;133(Pt 6):1779-97. doi: 10.1093/brain/awq103. Epub 2010 May 17.

PMID:
20483717
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk